Editas Medicine (EDIT) Accounts Payables (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Accounts Payables data on file, last reported at $2.6 million in Q4 2025.

• Accounts Payables for Q4 2025 came in at $2.6 million, down 52.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.6 million (down 52.58% YoY), and the FY2025 annual result was $2.6 million, down 52.58% from the prior year.
• Accounts Payables retreated to $2.6 million in Q4 2025 per EDIT's latest filing, from $3.2 million in the prior quarter.
• Over five years, Accounts Payables peaked at $13.8 million in Q2 2024 and troughed at $2.6 million in Q4 2025.
• A 5-year average of $7.1 million and a median of $6.8 million in 2022 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables surged 100.94% in 2022, then sank 74.68% in 2025.
• A 5-year view of Accounts Payables shows it stood at $5.0 million in 2021, then surged by 88.34% to $9.5 million in 2022, then decreased by 13.06% to $8.3 million in 2023, then sank by 33.57% to $5.5 million in 2024, then tumbled by 52.58% to $2.6 million in 2025.
• Business Quant data shows EDIT's Accounts Payables at $2.6 million in Q4 2025, $3.2 million in Q3 2025, and $6.7 million in Q2 2025.